The nurse teaches a client who is prescribed levalbuterol inhalation solution for reversible bronchospasm. Which statement by the client indicates correct understanding?
1I will use it as my daily anti-inflammatory controller instead of the prescribed corticosteroid.
2I will take extra treatments whenever symptoms return without reporting increased use.
3I will use it to prevent atrial fibrillation because it slows cardiac conduction.
4I will use it as prescribed for bronchospasm and report increased use, palpitations, or tremor.✓ Correct answer
Explanation
Levalbuterol is a short-acting beta-2 agonist used to treat or prevent bronchospasm in reversible obstructive airway disease. A need for more doses than usual can indicate worsening asthma and requires treatment reassessment. Palpitations, tachycardia, and tremor can occur and should be reported when significant. Levalbuterol does not replace anti-inflammatory corticosteroid therapy and does not prevent atrial fibrillation.
Clinical reasoning Levalbuterol relaxes bronchial smooth muscle through beta-2 receptor stimulation, but systemic adrenergic effects can produce tremor and cardiovascular symptoms.
Decision rule Use the prescribed dose for bronchospasm. Do not self-escalate repeated treatments; report increasing rescue needs or important palpitations, chest symptoms, or tremor for reassessment.
Scenario 72-year-old male with COPD, atrial fibrillation. Albuterol nebulizer causes palpitations, HR 130. Provider switches to levalbuterol 1.25 mg nebulizer.
Levalbuterol — The R-enantiomer of albuterol and a short-acting beta-2 agonist used to treat or prevent reversible bronchospasm.
Beta-2 agonist adverse effects — Adrenergic stimulation can cause palpitations, tachycardia, tremor, nervousness, glucose changes, and hypokalemia.
Cardiac comorbidity — AF, CHF, CAD; consider levalbuterol or careful albuterol monitoring.